Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
How Orphan Drugs Became a Highly Profitable Industry
Saturday, May 5, 2018
How Orphan Drugs Became a Highly Profitable Industry
The Scientist; By Diana Kwon | May 1, 2018
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
How Orphan Drugs Became a Highly Profitable Industry
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
How Orphan Drugs Became a Highly Profitable Industry
